ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Bacillus Calmette Guerin Vaccine Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-1Y11423
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Bacillus Calmette Guerin Vaccine Market Research Report 2022
BUY CHAPTERS

Global Bacillus Calmette Guerin Vaccine Market Research Report 2025

Code: QYRE-Auto-1Y11423
Report
January 2025
Pages:99
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
AJ Vaccines
Serum Institute of India
Intervax
GSBPL
Statens Serum Institute
Biomed Lublin
BB-NCIPD
Taj Pharmaceuticals
Bio-Farma
Microgen
IVAC
ANLIS Malbran
Fundação Ataulpho de Paiva
Torlakinstitut
Institut Pasteur de Tunis

Bacillus Calmette Guerin Vaccine Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Bacillus Calmette Guerin Vaccine Market

Bacillus Calmette Guerin Vaccine Market

The global market for Bacillus Calmette Guerin Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Bacillus Calmette Guerin Vaccine provides immunity or protection against tuberculosis (TB). The vaccine may be given to persons at high risk of developing TB.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Bacillus Calmette Guerin Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bacillus Calmette Guerin Vaccine.
The Bacillus Calmette Guerin Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bacillus Calmette Guerin Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bacillus Calmette Guerin Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Bacillus Calmette Guerin Vaccine Market Report

Report Metric Details
Report Name Bacillus Calmette Guerin Vaccine Market
CAGR 5%
Segment by Type
  • Immune Type
  • Therapy Type
Segment by Application
  • Hospitals
  • Clinics
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, AJ Vaccines, Serum Institute of India, Intervax, GSBPL, Statens Serum Institute, Biomed Lublin, ANLIS Malbran, Fundação Ataulpho de Paiva, BB-NCIPD, Taj Pharmaceuticals, Bio Farma, Microgen, Torlakinstitut, Institut Pasteur de Tunis, IVAC
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Bacillus Calmette Guerin Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Bacillus Calmette Guerin Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Bacillus Calmette Guerin Vaccine Market report?

Ans: The main players in the Bacillus Calmette Guerin Vaccine Market are Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, AJ Vaccines, Serum Institute of India, Intervax, GSBPL, Statens Serum Institute, Biomed Lublin, ANLIS Malbran, Fundação Ataulpho de Paiva, BB-NCIPD, Taj Pharmaceuticals, Bio Farma, Microgen, Torlakinstitut, Institut Pasteur de Tunis, IVAC

What are the Application segmentation covered in the Bacillus Calmette Guerin Vaccine Market report?

Ans: The Applications covered in the Bacillus Calmette Guerin Vaccine Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Bacillus Calmette Guerin Vaccine Market report?

Ans: The Types covered in the Bacillus Calmette Guerin Vaccine Market report are Immune Type, Therapy Type

Recommended Reports

Tuberculosis & BCG

Influenza & Viral Vaccines

Pediatric & General Vaccines

1 Bacillus Calmette Guerin Vaccine Market Overview
1.1 Product Definition
1.2 Bacillus Calmette Guerin Vaccine by Type
1.2.1 Global Bacillus Calmette Guerin Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Immune Type
1.2.3 Therapy Type
1.3 Bacillus Calmette Guerin Vaccine by Application
1.3.1 Global Bacillus Calmette Guerin Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Bacillus Calmette Guerin Vaccine Market Size Estimates and Forecasts
1.4.1 Global Bacillus Calmette Guerin Vaccine Revenue 2020-2031
1.4.2 Global Bacillus Calmette Guerin Vaccine Sales 2020-2031
1.4.3 Global Bacillus Calmette Guerin Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Bacillus Calmette Guerin Vaccine Market Competition by Manufacturers
2.1 Global Bacillus Calmette Guerin Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Bacillus Calmette Guerin Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Bacillus Calmette Guerin Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Bacillus Calmette Guerin Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Bacillus Calmette Guerin Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bacillus Calmette Guerin Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Bacillus Calmette Guerin Vaccine, Date of Enter into This Industry
2.8 Global Bacillus Calmette Guerin Vaccine Market Competitive Situation and Trends
2.8.1 Global Bacillus Calmette Guerin Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Bacillus Calmette Guerin Vaccine Players Market Share by Revenue
2.8.3 Global Bacillus Calmette Guerin Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Bacillus Calmette Guerin Vaccine Market Scenario by Region
3.1 Global Bacillus Calmette Guerin Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Bacillus Calmette Guerin Vaccine Sales by Region: 2020-2031
3.2.1 Global Bacillus Calmette Guerin Vaccine Sales by Region: 2020-2025
3.2.2 Global Bacillus Calmette Guerin Vaccine Sales by Region: 2026-2031
3.3 Global Bacillus Calmette Guerin Vaccine Revenue by Region: 2020-2031
3.3.1 Global Bacillus Calmette Guerin Vaccine Revenue by Region: 2020-2025
3.3.2 Global Bacillus Calmette Guerin Vaccine Revenue by Region: 2026-2031
3.4 North America Bacillus Calmette Guerin Vaccine Market Facts & Figures by Country
3.4.1 North America Bacillus Calmette Guerin Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Bacillus Calmette Guerin Vaccine Sales by Country (2020-2031)
3.4.3 North America Bacillus Calmette Guerin Vaccine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Bacillus Calmette Guerin Vaccine Market Facts & Figures by Country
3.5.1 Europe Bacillus Calmette Guerin Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Bacillus Calmette Guerin Vaccine Sales by Country (2020-2031)
3.5.3 Europe Bacillus Calmette Guerin Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bacillus Calmette Guerin Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Bacillus Calmette Guerin Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Bacillus Calmette Guerin Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Bacillus Calmette Guerin Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Bacillus Calmette Guerin Vaccine Market Facts & Figures by Country
3.7.1 Latin America Bacillus Calmette Guerin Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Bacillus Calmette Guerin Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Bacillus Calmette Guerin Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Bacillus Calmette Guerin Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Bacillus Calmette Guerin Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Bacillus Calmette Guerin Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Bacillus Calmette Guerin Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Bacillus Calmette Guerin Vaccine Sales by Type (2020-2031)
4.1.1 Global Bacillus Calmette Guerin Vaccine Sales by Type (2020-2025)
4.1.2 Global Bacillus Calmette Guerin Vaccine Sales by Type (2026-2031)
4.1.3 Global Bacillus Calmette Guerin Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Bacillus Calmette Guerin Vaccine Revenue by Type (2020-2031)
4.2.1 Global Bacillus Calmette Guerin Vaccine Revenue by Type (2020-2025)
4.2.2 Global Bacillus Calmette Guerin Vaccine Revenue by Type (2026-2031)
4.2.3 Global Bacillus Calmette Guerin Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Bacillus Calmette Guerin Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Bacillus Calmette Guerin Vaccine Sales by Application (2020-2031)
5.1.1 Global Bacillus Calmette Guerin Vaccine Sales by Application (2020-2025)
5.1.2 Global Bacillus Calmette Guerin Vaccine Sales by Application (2026-2031)
5.1.3 Global Bacillus Calmette Guerin Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Bacillus Calmette Guerin Vaccine Revenue by Application (2020-2031)
5.2.1 Global Bacillus Calmette Guerin Vaccine Revenue by Application (2020-2025)
5.2.2 Global Bacillus Calmette Guerin Vaccine Revenue by Application (2026-2031)
5.2.3 Global Bacillus Calmette Guerin Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Bacillus Calmette Guerin Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Bacillus Calmette Guerin Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck Bacillus Calmette Guerin Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Sanofi Pasteur
6.2.1 Sanofi Pasteur Company Information
6.2.2 Sanofi Pasteur Description and Business Overview
6.2.3 Sanofi Pasteur Bacillus Calmette Guerin Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sanofi Pasteur Bacillus Calmette Guerin Vaccine Product Portfolio
6.2.5 Sanofi Pasteur Recent Developments/Updates
6.3 Japan BCG Lab
6.3.1 Japan BCG Lab Company Information
6.3.2 Japan BCG Lab Description and Business Overview
6.3.3 Japan BCG Lab Bacillus Calmette Guerin Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Japan BCG Lab Bacillus Calmette Guerin Vaccine Product Portfolio
6.3.5 Japan BCG Lab Recent Developments/Updates
6.4 China National Biotec
6.4.1 China National Biotec Company Information
6.4.2 China National Biotec Description and Business Overview
6.4.3 China National Biotec Bacillus Calmette Guerin Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 China National Biotec Bacillus Calmette Guerin Vaccine Product Portfolio
6.4.5 China National Biotec Recent Developments/Updates
6.5 AJ Vaccines
6.5.1 AJ Vaccines Company Information
6.5.2 AJ Vaccines Description and Business Overview
6.5.3 AJ Vaccines Bacillus Calmette Guerin Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 AJ Vaccines Bacillus Calmette Guerin Vaccine Product Portfolio
6.5.5 AJ Vaccines Recent Developments/Updates
6.6 Serum Institute of India
6.6.1 Serum Institute of India Company Information
6.6.2 Serum Institute of India Description and Business Overview
6.6.3 Serum Institute of India Bacillus Calmette Guerin Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Serum Institute of India Bacillus Calmette Guerin Vaccine Product Portfolio
6.6.5 Serum Institute of India Recent Developments/Updates
6.7 Intervax
6.7.1 Intervax Company Information
6.7.2 Intervax Description and Business Overview
6.7.3 Intervax Bacillus Calmette Guerin Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Intervax Bacillus Calmette Guerin Vaccine Product Portfolio
6.7.5 Intervax Recent Developments/Updates
6.8 GSBPL
6.8.1 GSBPL Company Information
6.8.2 GSBPL Description and Business Overview
6.8.3 GSBPL Bacillus Calmette Guerin Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 GSBPL Bacillus Calmette Guerin Vaccine Product Portfolio
6.8.5 GSBPL Recent Developments/Updates
6.9 Statens Serum Institute
6.9.1 Statens Serum Institute Company Information
6.9.2 Statens Serum Institute Description and Business Overview
6.9.3 Statens Serum Institute Bacillus Calmette Guerin Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Statens Serum Institute Bacillus Calmette Guerin Vaccine Product Portfolio
6.9.5 Statens Serum Institute Recent Developments/Updates
6.10 Biomed Lublin
6.10.1 Biomed Lublin Company Information
6.10.2 Biomed Lublin Description and Business Overview
6.10.3 Biomed Lublin Bacillus Calmette Guerin Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Biomed Lublin Bacillus Calmette Guerin Vaccine Product Portfolio
6.10.5 Biomed Lublin Recent Developments/Updates
6.11 ANLIS Malbran
6.11.1 ANLIS Malbran Company Information
6.11.2 ANLIS Malbran Description and Business Overview
6.11.3 ANLIS Malbran Bacillus Calmette Guerin Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 ANLIS Malbran Bacillus Calmette Guerin Vaccine Product Portfolio
6.11.5 ANLIS Malbran Recent Developments/Updates
6.12 Fundação Ataulpho de Paiva
6.12.1 Fundação Ataulpho de Paiva Company Information
6.12.2 Fundação Ataulpho de Paiva Description and Business Overview
6.12.3 Fundação Ataulpho de Paiva Bacillus Calmette Guerin Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Fundação Ataulpho de Paiva Bacillus Calmette Guerin Vaccine Product Portfolio
6.12.5 Fundação Ataulpho de Paiva Recent Developments/Updates
6.13 BB-NCIPD
6.13.1 BB-NCIPD Company Information
6.13.2 BB-NCIPD Description and Business Overview
6.13.3 BB-NCIPD Bacillus Calmette Guerin Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.13.4 BB-NCIPD Bacillus Calmette Guerin Vaccine Product Portfolio
6.13.5 BB-NCIPD Recent Developments/Updates
6.14 Taj Pharmaceuticals
6.14.1 Taj Pharmaceuticals Company Information
6.14.2 Taj Pharmaceuticals Description and Business Overview
6.14.3 Taj Pharmaceuticals Bacillus Calmette Guerin Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Taj Pharmaceuticals Bacillus Calmette Guerin Vaccine Product Portfolio
6.14.5 Taj Pharmaceuticals Recent Developments/Updates
6.15 Bio Farma
6.15.1 Bio Farma Company Information
6.15.2 Bio Farma Description and Business Overview
6.15.3 Bio Farma Bacillus Calmette Guerin Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Bio Farma Bacillus Calmette Guerin Vaccine Product Portfolio
6.15.5 Bio Farma Recent Developments/Updates
6.16 Microgen
6.16.1 Microgen Company Information
6.16.2 Microgen Description and Business Overview
6.16.3 Microgen Bacillus Calmette Guerin Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Microgen Bacillus Calmette Guerin Vaccine Product Portfolio
6.16.5 Microgen Recent Developments/Updates
6.17 Torlakinstitut
6.17.1 Torlakinstitut Company Information
6.17.2 Torlakinstitut Description and Business Overview
6.17.3 Torlakinstitut Bacillus Calmette Guerin Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Torlakinstitut Bacillus Calmette Guerin Vaccine Product Portfolio
6.17.5 Torlakinstitut Recent Developments/Updates
6.18 Institut Pasteur de Tunis
6.18.1 Institut Pasteur de Tunis Company Information
6.18.2 Institut Pasteur de Tunis Description and Business Overview
6.18.3 Institut Pasteur de Tunis Bacillus Calmette Guerin Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Institut Pasteur de Tunis Bacillus Calmette Guerin Vaccine Product Portfolio
6.18.5 Institut Pasteur de Tunis Recent Developments/Updates
6.19 IVAC
6.19.1 IVAC Company Information
6.19.2 IVAC Description and Business Overview
6.19.3 IVAC Bacillus Calmette Guerin Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.19.4 IVAC Bacillus Calmette Guerin Vaccine Product Portfolio
6.19.5 IVAC Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bacillus Calmette Guerin Vaccine Industry Chain Analysis
7.2 Bacillus Calmette Guerin Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bacillus Calmette Guerin Vaccine Production Mode & Process Analysis
7.4 Bacillus Calmette Guerin Vaccine Sales and Marketing
7.4.1 Bacillus Calmette Guerin Vaccine Sales Channels
7.4.2 Bacillus Calmette Guerin Vaccine Distributors
7.5 Bacillus Calmette Guerin Vaccine Customer Analysis
8 Bacillus Calmette Guerin Vaccine Market Dynamics
8.1 Bacillus Calmette Guerin Vaccine Industry Trends
8.2 Bacillus Calmette Guerin Vaccine Market Drivers
8.3 Bacillus Calmette Guerin Vaccine Market Challenges
8.4 Bacillus Calmette Guerin Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
AJ Vaccines
Serum Institute of India
Intervax
GSBPL
Statens Serum Institute
Biomed Lublin
BB-NCIPD
Taj Pharmaceuticals
Bio-Farma
Microgen
IVAC
ANLIS Malbran
Fundação Ataulpho de Paiva
Torlakinstitut
Institut Pasteur de Tunis
List of Tables
 Table 1. Global Bacillus Calmette Guerin Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Bacillus Calmette Guerin Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Bacillus Calmette Guerin Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Bacillus Calmette Guerin Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Bacillus Calmette Guerin Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Bacillus Calmette Guerin Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Bacillus Calmette Guerin Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Bacillus Calmette Guerin Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Bacillus Calmette Guerin Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Bacillus Calmette Guerin Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Bacillus Calmette Guerin Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Bacillus Calmette Guerin Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Bacillus Calmette Guerin Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bacillus Calmette Guerin Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Bacillus Calmette Guerin Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Bacillus Calmette Guerin Vaccine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Bacillus Calmette Guerin Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global Bacillus Calmette Guerin Vaccine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Bacillus Calmette Guerin Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global Bacillus Calmette Guerin Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Bacillus Calmette Guerin Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global Bacillus Calmette Guerin Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Bacillus Calmette Guerin Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America Bacillus Calmette Guerin Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Bacillus Calmette Guerin Vaccine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Bacillus Calmette Guerin Vaccine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Bacillus Calmette Guerin Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Bacillus Calmette Guerin Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Bacillus Calmette Guerin Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Bacillus Calmette Guerin Vaccine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Bacillus Calmette Guerin Vaccine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Bacillus Calmette Guerin Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Bacillus Calmette Guerin Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Bacillus Calmette Guerin Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Bacillus Calmette Guerin Vaccine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Bacillus Calmette Guerin Vaccine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Bacillus Calmette Guerin Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Bacillus Calmette Guerin Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Bacillus Calmette Guerin Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Bacillus Calmette Guerin Vaccine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Bacillus Calmette Guerin Vaccine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Bacillus Calmette Guerin Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Bacillus Calmette Guerin Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Bacillus Calmette Guerin Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Bacillus Calmette Guerin Vaccine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Bacillus Calmette Guerin Vaccine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Bacillus Calmette Guerin Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Bacillus Calmette Guerin Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Bacillus Calmette Guerin Vaccine Sales (K Units) by Type (2020-2025)
 Table 51. Global Bacillus Calmette Guerin Vaccine Sales (K Units) by Type (2026-2031)
 Table 52. Global Bacillus Calmette Guerin Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global Bacillus Calmette Guerin Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global Bacillus Calmette Guerin Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Bacillus Calmette Guerin Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Bacillus Calmette Guerin Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global Bacillus Calmette Guerin Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global Bacillus Calmette Guerin Vaccine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Bacillus Calmette Guerin Vaccine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Bacillus Calmette Guerin Vaccine Sales (K Units) by Application (2020-2025)
 Table 61. Global Bacillus Calmette Guerin Vaccine Sales (K Units) by Application (2026-2031)
 Table 62. Global Bacillus Calmette Guerin Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global Bacillus Calmette Guerin Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global Bacillus Calmette Guerin Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Bacillus Calmette Guerin Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Bacillus Calmette Guerin Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global Bacillus Calmette Guerin Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global Bacillus Calmette Guerin Vaccine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Bacillus Calmette Guerin Vaccine Price (US$/Unit) by Application (2026-2031)
 Table 70. Merck Company Information
 Table 71. Merck Description and Business Overview
 Table 72. Merck Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Merck Bacillus Calmette Guerin Vaccine Product
 Table 74. Merck Recent Developments/Updates
 Table 75. Sanofi Pasteur Company Information
 Table 76. Sanofi Pasteur Description and Business Overview
 Table 77. Sanofi Pasteur Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Sanofi Pasteur Bacillus Calmette Guerin Vaccine Product
 Table 79. Sanofi Pasteur Recent Developments/Updates
 Table 80. Japan BCG Lab Company Information
 Table 81. Japan BCG Lab Description and Business Overview
 Table 82. Japan BCG Lab Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Japan BCG Lab Bacillus Calmette Guerin Vaccine Product
 Table 84. Japan BCG Lab Recent Developments/Updates
 Table 85. China National Biotec Company Information
 Table 86. China National Biotec Description and Business Overview
 Table 87. China National Biotec Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. China National Biotec Bacillus Calmette Guerin Vaccine Product
 Table 89. China National Biotec Recent Developments/Updates
 Table 90. AJ Vaccines Company Information
 Table 91. AJ Vaccines Description and Business Overview
 Table 92. AJ Vaccines Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. AJ Vaccines Bacillus Calmette Guerin Vaccine Product
 Table 94. AJ Vaccines Recent Developments/Updates
 Table 95. Serum Institute of India Company Information
 Table 96. Serum Institute of India Description and Business Overview
 Table 97. Serum Institute of India Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Serum Institute of India Bacillus Calmette Guerin Vaccine Product
 Table 99. Serum Institute of India Recent Developments/Updates
 Table 100. Intervax Company Information
 Table 101. Intervax Description and Business Overview
 Table 102. Intervax Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Intervax Bacillus Calmette Guerin Vaccine Product
 Table 104. Intervax Recent Developments/Updates
 Table 105. GSBPL Company Information
 Table 106. GSBPL Description and Business Overview
 Table 107. GSBPL Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. GSBPL Bacillus Calmette Guerin Vaccine Product
 Table 109. GSBPL Recent Developments/Updates
 Table 110. Statens Serum Institute Company Information
 Table 111. Statens Serum Institute Description and Business Overview
 Table 112. Statens Serum Institute Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Statens Serum Institute Bacillus Calmette Guerin Vaccine Product
 Table 114. Statens Serum Institute Recent Developments/Updates
 Table 115. Biomed Lublin Company Information
 Table 116. Biomed Lublin Description and Business Overview
 Table 117. Biomed Lublin Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Biomed Lublin Bacillus Calmette Guerin Vaccine Product
 Table 119. Biomed Lublin Recent Developments/Updates
 Table 120. ANLIS Malbran Company Information
 Table 121. ANLIS Malbran Description and Business Overview
 Table 122. ANLIS Malbran Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. ANLIS Malbran Bacillus Calmette Guerin Vaccine Product
 Table 124. ANLIS Malbran Recent Developments/Updates
 Table 125. Fundação Ataulpho de Paiva Company Information
 Table 126. Fundação Ataulpho de Paiva Description and Business Overview
 Table 127. Fundação Ataulpho de Paiva Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Fundação Ataulpho de Paiva Bacillus Calmette Guerin Vaccine Product
 Table 129. Fundação Ataulpho de Paiva Recent Developments/Updates
 Table 130. BB-NCIPD Company Information
 Table 131. BB-NCIPD Description and Business Overview
 Table 132. BB-NCIPD Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. BB-NCIPD Bacillus Calmette Guerin Vaccine Product
 Table 134. BB-NCIPD Recent Developments/Updates
 Table 135. Taj Pharmaceuticals Company Information
 Table 136. Taj Pharmaceuticals Description and Business Overview
 Table 137. Taj Pharmaceuticals Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Taj Pharmaceuticals Bacillus Calmette Guerin Vaccine Product
 Table 139. Taj Pharmaceuticals Recent Developments/Updates
 Table 140. Bio Farma Company Information
 Table 141. Bio Farma Description and Business Overview
 Table 142. Bio Farma Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Bio Farma Bacillus Calmette Guerin Vaccine Product
 Table 144. Bio Farma Recent Developments/Updates
 Table 145. Microgen Company Information
 Table 146. Microgen Description and Business Overview
 Table 147. Microgen Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Microgen Bacillus Calmette Guerin Vaccine Product
 Table 149. Microgen Recent Developments/Updates
 Table 150. Torlakinstitut Company Information
 Table 151. Torlakinstitut Description and Business Overview
 Table 152. Torlakinstitut Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Torlakinstitut Bacillus Calmette Guerin Vaccine Product
 Table 154. Torlakinstitut Recent Developments/Updates
 Table 155. Institut Pasteur de Tunis Company Information
 Table 156. Institut Pasteur de Tunis Description and Business Overview
 Table 157. Institut Pasteur de Tunis Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Institut Pasteur de Tunis Bacillus Calmette Guerin Vaccine Product
 Table 159. Institut Pasteur de Tunis Recent Developments/Updates
 Table 160. IVAC Company Information
 Table 161. IVAC Description and Business Overview
 Table 162. IVAC Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. IVAC Bacillus Calmette Guerin Vaccine Product
 Table 164. IVAC Recent Developments/Updates
 Table 165. Key Raw Materials Lists
 Table 166. Raw Materials Key Suppliers Lists
 Table 167. Bacillus Calmette Guerin Vaccine Distributors List
 Table 168. Bacillus Calmette Guerin Vaccine Customers List
 Table 169. Bacillus Calmette Guerin Vaccine Market Trends
 Table 170. Bacillus Calmette Guerin Vaccine Market Drivers
 Table 171. Bacillus Calmette Guerin Vaccine Market Challenges
 Table 172. Bacillus Calmette Guerin Vaccine Market Restraints
 Table 173. Research Programs/Design for This Report
 Table 174. Key Data Information from Secondary Sources
 Table 175. Key Data Information from Primary Sources
 Table 176. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Bacillus Calmette Guerin Vaccine
 Figure 2. Global Bacillus Calmette Guerin Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Bacillus Calmette Guerin Vaccine Market Share by Type: 2024 & 2031
 Figure 4. Immune Type Product Picture
 Figure 5. Therapy Type Product Picture
 Figure 6. Global Bacillus Calmette Guerin Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Bacillus Calmette Guerin Vaccine Market Share by Application: 2024 & 2031
 Figure 8. Hospitals
 Figure 9. Clinics
 Figure 10. Others
 Figure 11. Global Bacillus Calmette Guerin Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Bacillus Calmette Guerin Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Bacillus Calmette Guerin Vaccine Sales (2020-2031) & (K Units)
 Figure 14. Global Bacillus Calmette Guerin Vaccine Average Price (US$/Unit) & (2020-2031)
 Figure 15. Bacillus Calmette Guerin Vaccine Report Years Considered
 Figure 16. Bacillus Calmette Guerin Vaccine Sales Share by Manufacturers in 2024
 Figure 17. Global Bacillus Calmette Guerin Vaccine Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Bacillus Calmette Guerin Vaccine Players: Market Share by Revenue in Bacillus Calmette Guerin Vaccine in 2024
 Figure 19. Bacillus Calmette Guerin Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Bacillus Calmette Guerin Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Bacillus Calmette Guerin Vaccine Sales Market Share by Country (2020-2031)
 Figure 22. North America Bacillus Calmette Guerin Vaccine Revenue Market Share by Country (2020-2031)
 Figure 23. United States Bacillus Calmette Guerin Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Bacillus Calmette Guerin Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Bacillus Calmette Guerin Vaccine Sales Market Share by Country (2020-2031)
 Figure 26. Europe Bacillus Calmette Guerin Vaccine Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Bacillus Calmette Guerin Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Bacillus Calmette Guerin Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Bacillus Calmette Guerin Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Bacillus Calmette Guerin Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Bacillus Calmette Guerin Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Bacillus Calmette Guerin Vaccine Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Bacillus Calmette Guerin Vaccine Revenue Market Share by Region (2020-2031)
 Figure 34. China Bacillus Calmette Guerin Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Bacillus Calmette Guerin Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Bacillus Calmette Guerin Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Bacillus Calmette Guerin Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Bacillus Calmette Guerin Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Bacillus Calmette Guerin Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Bacillus Calmette Guerin Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Bacillus Calmette Guerin Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Bacillus Calmette Guerin Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Bacillus Calmette Guerin Vaccine Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Bacillus Calmette Guerin Vaccine Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Bacillus Calmette Guerin Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Bacillus Calmette Guerin Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Bacillus Calmette Guerin Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Bacillus Calmette Guerin Vaccine Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Bacillus Calmette Guerin Vaccine Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Bacillus Calmette Guerin Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Bacillus Calmette Guerin Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Bacillus Calmette Guerin Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Bacillus Calmette Guerin Vaccine by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Bacillus Calmette Guerin Vaccine by Type (2020-2031)
 Figure 55. Global Bacillus Calmette Guerin Vaccine Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Bacillus Calmette Guerin Vaccine by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Bacillus Calmette Guerin Vaccine by Application (2020-2031)
 Figure 58. Global Bacillus Calmette Guerin Vaccine Price (US$/Unit) by Application (2020-2031)
 Figure 59. Bacillus Calmette Guerin Vaccine Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Bacille Calmette Guerin Vaccine Market Research Report 2024
Global TB Disease Vaccine Market Research Report 2025
Global BCG Vaccine for Tuberculosis TB Market Research Report 2025
Global TB Vaccines Market Insights Forecast to 2030
Global BCG Vaccine Market Insights Forecast to 2030
Global BCG and Tuberculosis Vaccine Market Research Report 2025
Global BCG Vaccination Market Research Report 2025
BCG Tuberculosis TB Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tuberculosis Vaccination Market Research Report 2025
Global BCG Vaccine for Intradermal Injection Market Research Report 2024
Global Therapeutic BCG Vaccines Market Insights Forecast to 2030
Tuberculosis Vaccine Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Tuberculosis Vaccine Market Research Report 2025
Global Mycobacterium Tuberculosis Antibodies Market Research Report 2024
TB Vaccine Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Bacille Calmette Guérin Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global HIV Vaccine Market Research Report 2025
Tuberculosis Prevention and Treatment Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tuberculosis Vaccine for Vhildren Market Research Report 2024
Global HIV and AIDS Vaccine Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions